Cargando…

Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations

The aim of this study was the optimization of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in terms of physicochemical and biopharmaceutical properties, to develop effective and stable aqueous liquid formulations of hydrochlorothiazide, suitable for paediatric therapy, ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Mura, Paola, Maestrelli, Francesca, D’Ambrosio, Mario, Luceri, Cristina, Cirri, Marzia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063941/
https://www.ncbi.nlm.nih.gov/pubmed/33804945
http://dx.doi.org/10.3390/pharmaceutics13040437
_version_ 1783682041013862400
author Mura, Paola
Maestrelli, Francesca
D’Ambrosio, Mario
Luceri, Cristina
Cirri, Marzia
author_facet Mura, Paola
Maestrelli, Francesca
D’Ambrosio, Mario
Luceri, Cristina
Cirri, Marzia
author_sort Mura, Paola
collection PubMed
description The aim of this study was the optimization of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in terms of physicochemical and biopharmaceutical properties, to develop effective and stable aqueous liquid formulations of hydrochlorothiazide, suitable for paediatric therapy, overcoming its low-solubility and poor-stability problems. Based on solubility studies, Precirol(®) ATO5 and Transcutol(®) HP were used as solid and liquid lipids, respectively. The effect of different surfactants, also in different combinations and at different amounts, on particle size, homogeneity and surface-charge of nanoparticles was carefully investigated. The best formulations were selected for drug loading, and evaluated also for entrapment efficiency and release behaviour. For both SLN and NLC series, the use of Gelucire(®) 44/14 as surfactant rather than PluronicF68 or Tween(®) 80 yielded a marked particle size reduction (95–75 nm compared to around 600–400 nm), and an improvement in entrapment efficiency and drug release rate. NLC showed a better performance than SLN, reaching about 90% entrapped drug (vs. 80%) and more than 90% drug released after 300 min (vs. about 65%). All selected formulations showed good physical stability during 6-month storage at 4 °C, but a higher loss of encapsulated drug was found for SLNs (15%) than for NLCs (<5%). Moreover, all selected formulations revealed the absence of any cytotoxic effect, as assessed by a cell-viability test on Caco-2 cells and are able to pass the intestinal epithelium as suggested by Caco-2 uptake experiments.
format Online
Article
Text
id pubmed-8063941
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80639412021-04-24 Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations Mura, Paola Maestrelli, Francesca D’Ambrosio, Mario Luceri, Cristina Cirri, Marzia Pharmaceutics Article The aim of this study was the optimization of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in terms of physicochemical and biopharmaceutical properties, to develop effective and stable aqueous liquid formulations of hydrochlorothiazide, suitable for paediatric therapy, overcoming its low-solubility and poor-stability problems. Based on solubility studies, Precirol(®) ATO5 and Transcutol(®) HP were used as solid and liquid lipids, respectively. The effect of different surfactants, also in different combinations and at different amounts, on particle size, homogeneity and surface-charge of nanoparticles was carefully investigated. The best formulations were selected for drug loading, and evaluated also for entrapment efficiency and release behaviour. For both SLN and NLC series, the use of Gelucire(®) 44/14 as surfactant rather than PluronicF68 or Tween(®) 80 yielded a marked particle size reduction (95–75 nm compared to around 600–400 nm), and an improvement in entrapment efficiency and drug release rate. NLC showed a better performance than SLN, reaching about 90% entrapped drug (vs. 80%) and more than 90% drug released after 300 min (vs. about 65%). All selected formulations showed good physical stability during 6-month storage at 4 °C, but a higher loss of encapsulated drug was found for SLNs (15%) than for NLCs (<5%). Moreover, all selected formulations revealed the absence of any cytotoxic effect, as assessed by a cell-viability test on Caco-2 cells and are able to pass the intestinal epithelium as suggested by Caco-2 uptake experiments. MDPI 2021-03-24 /pmc/articles/PMC8063941/ /pubmed/33804945 http://dx.doi.org/10.3390/pharmaceutics13040437 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Mura, Paola
Maestrelli, Francesca
D’Ambrosio, Mario
Luceri, Cristina
Cirri, Marzia
Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations
title Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations
title_full Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations
title_fullStr Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations
title_full_unstemmed Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations
title_short Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations
title_sort evaluation and comparison of solid lipid nanoparticles (slns) and nanostructured lipid carriers (nlcs) as vectors to develop hydrochlorothiazide effective and safe pediatric oral liquid formulations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063941/
https://www.ncbi.nlm.nih.gov/pubmed/33804945
http://dx.doi.org/10.3390/pharmaceutics13040437
work_keys_str_mv AT murapaola evaluationandcomparisonofsolidlipidnanoparticlesslnsandnanostructuredlipidcarriersnlcsasvectorstodevelophydrochlorothiazideeffectiveandsafepediatricoralliquidformulations
AT maestrellifrancesca evaluationandcomparisonofsolidlipidnanoparticlesslnsandnanostructuredlipidcarriersnlcsasvectorstodevelophydrochlorothiazideeffectiveandsafepediatricoralliquidformulations
AT dambrosiomario evaluationandcomparisonofsolidlipidnanoparticlesslnsandnanostructuredlipidcarriersnlcsasvectorstodevelophydrochlorothiazideeffectiveandsafepediatricoralliquidformulations
AT lucericristina evaluationandcomparisonofsolidlipidnanoparticlesslnsandnanostructuredlipidcarriersnlcsasvectorstodevelophydrochlorothiazideeffectiveandsafepediatricoralliquidformulations
AT cirrimarzia evaluationandcomparisonofsolidlipidnanoparticlesslnsandnanostructuredlipidcarriersnlcsasvectorstodevelophydrochlorothiazideeffectiveandsafepediatricoralliquidformulations